Header Logo

Beverly E Sha

TitleProfessor
InstitutionRush University, Rush Medical College
DepartmentInfectious Diseases
AddressChicago IL 60612
vCardDownload vCard

    Collapse Overview 
    Collapse overview
    My Scopus ID is 7005779955.
    My NIH COMMONS name is BSHA123

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Yonko EA, Tian J, Aminzadeh K, Qian Y, Noori G, Plankey M, Friedman MR, Palella FJ, Jones DL, Wingood G, Sharma A, Dionne JA, Edmonds A, Sha BE, Aouizerat BE, Spence A, Wilson T, Detels R, Mimiaga MJ. The Relationship Between HIV Preexposure Prophylaxis Use and Laboratory-Confirmed Bacterial Sexually Transmitted Infection Positivity Among a Diverse, Multi-City Cohort of Sexually Active Sexual and Gender Minorities in the United States. AIDS Patient Care STDS. 2026 01; 40(1):21-30. PMID: 41147878; PMCID: PMC12697303.
      Citations:    
    2. McNulty MC, Stanford KA, Eller D, Sha BE, Purim-Shem-Tov Y, Kishen E, Glick N, Hunt B, Lin JY, Maheswaran A, Galvin S, Turelli R, Schmitt J, Pitrak D. Concurrent Testing for COVID-19 and HIV Infection at 6 High-Volume Emergency Departments in a Priority Jurisdiction for Ending the HIV Epidemic in the United States. J Acquir Immune Defic Syndr. 2023 12 01; 94(4):364-370. PMID: 37884056.
      Citations:    
    3. Maaske J, Sproule S, Falsey AR, Sobieszczyk ME, Luetkemeyer AF, Paulsen GC, Riddler SA, Robb ML, Rolle CP, Sha BE, Tong T, Ahani B, Aksyuk AA, Bansal H, Egan T, Jepson B, Padilla M, Patel N, Shoemaker K, Stanley AM, Swanson PA, Wilkins D, Villafana T, Green JA, Kelly EJ. Robust humoral and cellular recall responses to AZD1222 attenuate breakthrough SARS-CoV-2 infection compared to unvaccinated. Front Immunol. 2022; 13:1062067. PMID: 36713413.
      Citations:    
    4. Ash MK, Bhimalli PP, Cho BK, Mattamana BB, Gambut S, Tarhoni I, Fhied CL, Reyes AF, Welninski SJ, Arivalagan J, Negr?o F, Goel R, Beck TL, Hope TJ, Sha BE, Goo YA, Al-Harthi L, Mamede JI, Borgia JA, Kelleher NL, Schneider JR, Ash MK, Bhimalli PP, Cho BK, Mattamana BB, Gambut S, Tarhoni I, Fhied CL, Reyes AF, Welninski SJ, Arivalagan J, Negr?o F, Goel R, Beck TL, Hope TJ, Sha BE, Goo YA, Al-Harthi L, Mamede JI, Borgia JA, Kelleher NL, Schneider JR. Bulk IgG glycosylation predicts COVID-19 severity and vaccine antibody response. Cell Rep. 2022 12 13; 41(11):111799. PMID: 36493786; PMCID: PMC9678812.
      Citations:    
    5. Melani RD, Soye BJD, Kafader JO, Forte E, Hollas M, Blagojevic V, Negr?o F, McGee JP, Drown B, Lloyd-Jones C, Seckler HS, Camarillo JM, Compton PD, LeDuc RD, Early B, Fellers RT, Cho BK, Mattamana BB, Goo YA, Thomas PM, Ash MK, Bhimalli PP, Al-Harthi L, Sha BE, Schneider JR, Kelleher NL. Next-generation Serology by Mass Spectrometry: Readout of the SARS-CoV-2 Antibody Repertoire. medRxiv. 2021 Jul 07. PMID: 34268518.
      Citations:    
    6. Virdi AK, Wallace J, Barbian H, Richards MH, Ritz EM, Sha B, Al-Harthi L. CD32 is enriched on CD4dimCD8bright T cells. PLoS One. 2020; 15(9):e0239157. PMID: 32960910.
      Citations:    
    7. Sha BE, Kniuksta R, Exner K, Kishen E, Shankaran S, Williams B, Aziz M, Lai R, Purim-Shem-Tov Y. Evolution of an Electronic Health Record Based-Human Immunodeficiency Virus (HIV) Screening Program in an Urban Emergency Department for Diagnosing Acute and Chronic HIV Infection. J Emerg Med. 2019 11; 57(5):732-739. PMID: 31629580.
      Citations:    
    8. Sha BE. Adult Immunization Update. JAMA. 2019 Sep 17; 322(11):1096-1097. PMID: 31424523.
      Citations:    
    9. Nyaku AN, Zheng L, Gulick RM, Olefsky M, Berzins B, Wallis CL, Godfrey C, Sax PE, Acosta EP, Haas DW, Smith KY, Sha BE, Van Dam CN, Taiwo BO. Dolutegravir plus lamivudine for initial treatment of HIV-1-infected participants with HIV-1 RNA <500?000 copies/mL: week 48 outcomes from ACTG 5353. J Antimicrob Chemother. 2019 05 01; 74(5):1376-1380. PMID: 30668695.
      Citations:    
    10. Fletcher FE, Vidrine DJ, Trejo MB, Molina Y, Sha BE, Floyd BR, Sarhene N, Mator J, Matthews AK. "You Come Back to the Same Ole Shit:" A Qualitative Study of Smoking Cessation Barriers among Women Living with HIV: Implications for Intervention Development. J Health Dispar Res Pract. 2019; 12(2):106-122. PMID: 32963893.
      Citations:    
    11. Burke-Miller JK, Weber K, Cohn SE, Hershow RC, Sha BE, French AL, Cohen MH. Neighborhood community characteristics associated with HIV disease outcomes in a cohort of urban women living with HIV. AIDS Care. 2016 10; 28(10):1274-9. PMID: 27098593.
      Citations:    
    12. Cheng JW, Hayden MK, Singh K, Heimler I, Gee JE, Proia L, Sha BE. Burkholderia pseudomallei Infection in US Traveler Returning from Mexico, 2014. Emerg Infect Dis. 2015 Oct; 21(10):1884-5. PMID: 26401597.
      Citations:    
    13. Swanson B, Keithley JK, Johnson A, Fogg L, Adeyemi O, Sha BE, Snell KA. Acupuncture to Reduce HIV-Associated Inflammation. Evid Based Complement Alternat Med. 2015; 2015:908538. PMID: 25922615.
      Citations:    
    14. Fu J, Sha BE, Thomas LL. HIV-1-infected peripheral blood mononuclear cells enhance neutrophil survival and HLA-DR expression via increased production of GM-CSF: implications for HIV-1 infection. J Acquir Immune Defic Syndr. 2011 Jan 01; 56(1):16-25. PMID: 20975570.
      Citations:    
    15. Sha BE, Tierney C, Cohn SE, Sun X, Coombs RW, Frenkel LM, Kalams SA, Aweeka FT, Bastow B, Bardeguez A, Kmack A, Stek A. Postpartum viral load rebound in HIV-1-infected women treated with highly active antiretroviral therapy: AIDS Clinical Trials Group Protocol A5150. HIV Clin Trials. 2011 Jan-Feb; 12(1):9-23. PMID: 21388937.
      Citations:    
    16. Swanson B, Sha BE, Keithley JK, Fogg L, Nerad J, Novak R, Adeyemi O. Lipoprotein Particle Profiles by Nuclear Magnetic Resonance Spectroscopy in Medically-Underserved HIV-Infected Persons. J Clin Lipidol. 2009 Dec 01; 3(6):379-384. PMID: 20161509.
      Citations:    
    17. Spear GT, Zariffard MR, Cohen MH, Sha BE. Vaginal IL-8 levels are positively associated with Candida albicans and inversely with lactobacilli in HIV-infected women. J Reprod Immunol. 2008 Jun; 78(1):76-9. PMID: 18243333.
      Citations:    
    18. Duckro AN, Sha BE, Jakate S, Hayden MK, Simon DM, Saltzberg SN, Arai S, Kessler HA. Herpes simplex virus hepatitis: expanding the spectrum of disease. Transpl Infect Dis. 2006 Sep; 8(3):171-6. PMID: 16913977.
      Citations:    
    19. Zariffard MR, Sha BE, Wang QJ, Chen HY, Bremer J, Cohen MH, Spear GT. Relationship of U1 cell HIV-stimulatory activity to bacterial vaginosis and HIV genital tract virus load. AIDS Res Hum Retroviruses. 2005 Nov; 21(11):945-8. PMID: 16386111.
      Citations:    
    20. Watts DH, Fazzari M, Fazarri M, Minkoff H, Hillier SL, Sha B, Glesby M, Levine AM, Burk R, Palefsky JM, Moxley M, Ahdieh-Grant L, Strickler HD. Effects of bacterial vaginosis and other genital infections on the natural history of human papillomavirus infection in HIV-1-infected and high-risk HIV-1-uninfected women. J Infect Dis. 2005 Apr 01; 191(7):1129-39. PMID: 15747249.
      Citations:    
    21. Rezai K, Kuchipudi S, Chundi V, Ariga R, Loew J, Sha BE. Kikuchi-Fujimoto disease: hydroxychloroquine as a treatment. Clin Infect Dis. 2004 Dec 15; 39(12):e124-6. PMID: 15578393.
      Citations:    
    22. Swanson B, Keithley JK, Zeller JM, Sha BE. Lack of association between dyslipidemia and insulin resistance in HIV-infected persons treated with highly active antiretroviral therapy. Nutrition. 2004 Nov-Dec; 20(11-12):1022-5. PMID: 15561494.
      Citations:    
    23. Kalayjian RC, Landay A, Pollard RB, Taub DD, Gross BH, Francis IR, Sevin A, Pu M, Spritzler J, Chernoff M, Namkung A, Fox L, Martinez A, Waterman K, Fiscus SA, Sha B, Johnson D, Slater S, Rousseau F, Lederman MM. Age-related immune dysfunction in health and in human immunodeficiency virus (HIV) disease: association of age and HIV infection with naive CD8+ cell depletion, reduced expression of CD28 on CD8+ cells, and reduced thymic volumes. J Infect Dis. 2003 Jun 15; 187(12):1924-33. PMID: 12792869.
      Citations:    
    24. Liu B, Lin ZB, Zeng FJ, Ming CS, Sha B, Chen ZS, Chen S. Single-center experience: tacrolimus and mycophenolate mofetil in early stage of kidney transplantation with liver dysfunction. Transplant Proc. 2003 Feb; 35(1):273-4. PMID: 12591396.
      Citations:    
    25. Keithley JK, Swanson B, Sha BE, Zeller JM, Kessler HA, Smith KY. A pilot study of the safety and efficacy of cholestin in treating HIV-related dyslipidemia. Nutrition. 2002 Feb; 18(2):201-4. PMID: 11844656.
      Citations:    
    26. Battle-Miller K, Eby CA, Landay AL, Cohen MH, Sha BE, Baum LL. Antibody-dependent cell-mediated cytotoxicity in cervical lavage fluids of human immunodeficiency virus type 1--infected women. J Infect Dis. 2002 Feb 15; 185(4):439-47. PMID: 11865395.
      Citations:    
    27. Keithley JK, Swanson B, Zeller JM, Sha BE, Cohen M, Hershow R, Novak R. Comparison of standard and immune-enhancing oral formulas in asymptomatic HIV-infected persons: a multicenter randomized controlled clinical trial. JPEN J Parenter Enteral Nutr. 2002 Jan-Feb; 26(1):6-14. PMID: 11833753.
      Citations:    
    28. Harris A, Forouhar F, Qiu S, Sha B, Luo M. The crystal structure of the influenza matrix protein M1 at neutral pH: M1-M1 protein interfaces can rotate in the oligomeric structures of M1. Virology. 2001 Oct 10; 289(1):34-44. PMID: 11601915.
      Citations:    
    29. Sha BE, Proia LA, Kessler HA. Adverse effects associated with use of nevirapine in HIV postexposure prophylaxis for 2 health care workers. JAMA. 2000 Dec 06; 284(21):2723. PMID: 11105176.
      Citations:    
    30. Al-Harthi L, Roebuck KA, Olinger GG, Landay A, Sha BE, Hashemi FB, Spear GT. Bacterial vaginosis-associated microflora isolated from the female genital tract activates HIV-1 expression. J Acquir Immune Defic Syndr. 1999 Jul 01; 21(3):194-202. PMID: 10421242.
      Citations:    
    31. Olivero OA, Shearer GM, Chougnet CA, Kovacs AA, Landay AL, Baker R, Stek AM, Khoury MM, Proia LA, Kessler HA, Sha BE, Tarone RE, Poirier MC. Incorporation of zidovudine into leukocyte DNA from HIV-1-positive adults and pregnant women, and cord blood from infants exposed in utero. AIDS. 1999 May 28; 13(8):919-25. PMID: 10371172.
      Citations:    
    32. Harris A, Sha B, Luo M. Structural similarities between influenza virus matrix protein M1 and human immunodeficiency virus matrix and capsid proteins: an evolutionary link between negative-stranded RNA viruses and retroviruses. J Gen Virol. 1999 Apr; 80 ( Pt 4):863-869. PMID: 10211954.
      Citations:    
    33. Takefman DM, Sullivan BL, Sha BE, Spear GT. Mechanisms of resistance of HIV-1 primary isolates to complement-mediated lysis. Virology. 1998 Jul 05; 246(2):370-8. PMID: 9657955.
      Citations:    
    34. Sha BE, D'Amico RD, Landay AL, Spear GT, Massad LS, Rydman RJ, Warner NA, Padnick J, Ackatz L, Charles LA, Benson CA. Evaluation of immunologic markers in cervicovaginal fluid of HIV-infected and uninfected women: implications for the immunologic response to HIV in the female genital tract. J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Nov 01; 16(3):161-8. PMID: 9390567.
      Citations:    
    35. Spear GT, al-Harthi L, Sha B, Saarloos MN, Hayden M, Massad LS, Benson C, Roebuck KA, Glick NR, Landay A. A potent activator of HIV-1 replication is present in the genital tract of a subset of HIV-1-infected and uninfected women. AIDS. 1997 Sep; 11(11):1319-26. PMID: 9302440.
      Citations:    
    36. Sullivan BL, Knopoff EJ, Saifuddin M, Takefman DM, Saarloos MN, Sha BE, Spear GT. Susceptibility of HIV-1 plasma virus to complement-mediated lysis. Evidence for a role in clearance of virus in vivo. J Immunol. 1996 Aug 15; 157(4):1791-8. PMID: 8759769.
      Citations:    
    37. Sullivan JF, Kessler HA, Sha BE. False-positive HIV test: implications for the patient. JAMA. 1993 Jun 09; 269(22):2847. PMID: 8497085.
      Citations:    
    38. Pottage JC, Benson CA, Sha BE, Urbanski P, Kessler HA. Treatment of patients with advanced HIV infection and zidovudine intolerance with dideoxyinosine. AIDS. 1992 Jul; 6(7):748-9. PMID: 1503699.
      Citations:    
    39. Sha BE, Harris AA, Benson CA, Atkinson WL, Urbanski PA, Stewart JA, Williams WW, Murphy RL, Phair JP, Levin SA, et al. Prevalence of measles antibodies in asymptomatic human immunodeficiency virus-infected adults. J Infect Dis. 1991 Nov; 164(5):973-5. PMID: 1682395.
      Citations:    
    40. Sha BE, Benson CA, Deutsch TA, Urbanski PA, Phair JP, Kessler HA. Suppression of cytomegalovirus retinitis in persons with AIDS with high-dose intravenous acyclovir. J Infect Dis. 1991 Oct; 164(4):777-80. PMID: 1654361.
      Citations:    
    41. Pottage JC, Sha BE. Development of histoplasmosis in a human immunodeficiency virus-infected patient receiving fluconazole. J Infect Dis. 1991 Sep; 164(3):622-3. PMID: 1869858.
      Citations:    
    Sha's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (252)
    Explore
    _
    Co-Authors (11)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _